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A B S T R A C T Bronchodilatation was produced in normal subjects by the inhalation of atropine, a parasympatholytic agent,.and isoproterenol, a beta adrenergic stimulator. Density dependence of maximal expiratory flow (Vmax) expressed as a ratio of Vmax with an 80% helium-20% oxygen gas mixture to Vmax with air at isolung volumes, indicated that the predominant flow regimes across upstream airways changed differently after each agent was given separately. After atropine Vmax increased, elastic recoil pressure did not change, and density dependence decreased. Utilizing the equal pressure points analysis which defines upstream and downstream segments of the intrathoracic airways at flow limitation, these results suggest a greater relative dilatation of the larger upstream airways such that more of the driving pressure is dissipated across the smaller airways in which flow is less dependent upon gas density. After isoproterenol Vmax increased, elastic recoil pressure did not change, and density dependence increased. This suggests a preferential dilatation of the smaller and more peripheral airways with less density-dependent flow regimes such that more of the driving pressure would be dissipated in the larger airways in which flow is more dependent upon gas density. Systematic decreases in critical alveolar pressures after atropine and increases after isoproterenol lead independently to the same conclusion. After both agents together, Vmax increased and density de- pendence and critical alveolar pressures did not change from control, suggesting a relatively uniform dilatation of all the airways comprising the upstream segment. INTRODUCTION Both atropine and isoproterenol dilate the airways of normal subjects. Widdicombe and associates (1) reported a 42% increase in specific airway conductance after subcutaneous atropine, and Severinghaus and Stupfel (2) demonstrated a 29-47% increase in anatomic dead space after this agent. Aerosolized isoproterenol also increases specific airway conductance and maximal expiratory flow (Vmax)1 (3, 4) . Thus, there exists bronchial smooth muscle tone that can be lessened with therapeutic agents in normal subjects. To determine the influence of the autonomic nervous system on the distribution of airway resistance, Woolcock et al. (5) , utilizing the retrograde catheter technique in dog lungs, demonstrated that bronchomotor tone is the result of a balance between parasympathetic and sympathetic influences. In this study, stimulation of the parasympathetic nervous system exerted a constricting influence at all levels ofthe tracheobronchial tree, but its effect on peripheral airways was inhibited by an intact sympathetic system. Since atropine blocks postganglionic cholinergic neural pathways and isoproterenol acts directly on bronchial smooth muscle by beta adrenergic stimulation, it is plausible that these different neuropharmacological agents might produce a relatively different distribution of bronchodilatation. Thus, atropine might tend to have more influience on the larger, central airways and isoproterenol iiight tend to exert more influence in the smaller, more peripheral airways. This present stuidy was designed to explore the site of bronchodilatation that was prodtuced in normal subjects by these agents.
METHODS
Seven normal subjects between the ages of 23 and 32 yr were studied after obtaining informed consent. All flow and volume measurements were made in an air-conditioned, integrated flow, pressure-corrected whole body plethysmograph (6) . The volume signal was statically calibrated before each set of measurements, and the signal was pressure corrected by means of shaping a rapid step input of volume (6) . Flow at the mouth was measured using a no. 4 Fleisch pneumotachograph (Dynamic Science Medical Products, Blue Ball, Pa.) with a Hewlett-Packard 270 differential pressuire transduicer (Hewlett-Packard Co., Palo Alto, Calif.). The pneumotachograph was linearized in the expiratory direction according to Finucane et al. (7) , and calibrated by passing gas mixtures through it at a wide range of flows. Maximal expiratory flow volume curves were obtained breathing air and after the washin of an 80% helium-20% oxygen (HeO2) gas mixture. The HeO2 washin was judged complete when the end-tidal nitrogen concentration was less than 3% as measured by a Med-Science 300 AR Nitralyzer (Med-Science Electronics, Inc., St. Louis, Mo.). The maximal expiratory flow volume curves were displayed as the x-y coordinates of a storage oscilloscope and then photographed. The curves with the highest maximal flows whose vital capacities on air and HeO2 matched exactly were chosen. After control measurements, each subject inhaled either 0.6 mg of atropine sulfate or 2.5 mg of isoproterenol, or both agents given together. Only one study was performed per day. Larger doses were given to three subjects, and the results were not found to be significantly different from those seen with amounts stated above. All aerosols were generated using the same nebulizing unit, driven by a Bennett PR-2 pressure-cycled respirator (Bennett Respiration Products, Inc., Santa Monica, Calif.). This procedure was followed so that the particle size of the aerosol, although not precisely known, would be constant for each agent. Another series of studies was performed on four of the seven subjects again on 3 separate days. Isovolume pressure flow (IVPF) curves were obtained before and after isoproterenol, atropine and isoproterenol plus atropine, by the methods of Hyatt and associates (9) . Instantaneous values of transpulmonary pressure and expiratory flow were plotted as the x-y coordinates of a storage oscilloscope at the same lung volume using a modified gating circuit (10) . Each vital capacity maneuver yielded one point at that lung volume. Although it is difficult to define precise values for Palv' on any IVPF curve, specific values were obtained by using the mean of five observations from five individuals experienced in such measuremnents who selected the Palv' in a single blind fashion from unlabeled xerographic reproductions. The IVPF relationships at volumes approximately 40-50% of the vital capacity were analyzed using the equal pressure point concept of Mlead et al. (11) 
(2)
(same as Eq. 5 in reference 3). Thuis, Palv' at a given Pst(l) depends only upon the ratio of uipstream and downstream resistances and, therefore, is independent of Rt. From this relationship, Palv' at a given Pst( 1) wouild be expected to decrease with increases in Vmax if there were a greater decrease in resistance of downstream pressture and to increase if there were a disproportionate fall in Rus.
The data were analyzed by t test for paired observations and by factorial analysis.
RESULTS
The static lung volumes did not change from control values after the bronchodilators were administered. Control residual volume (mean±SD), 1.62±0.33; atropine, 1.71±0.48; isoproterenol, 1.59+0.30, both agents, 1.72+0.35; F = 0.20; P NS. Control total lung capacity, 7.15±0.51; atropine, 7.25±0.57; isoproterenol, 7.15±0.56; both agents, 7.10±0.47; F = 0.04; P, NS.
The effects of atropine and isoproterenol on Vmax at 40% of vital capacity (Vmax4o), the degree of density dependence of Vmax4o, and calculated upstream resistances are shown for all subjects in Table I . There were significant increases in air flow rates for each agent alone and in combination when compared with control observations. The response to atropine was not significantly different from that to isoproterenol, nor was the atropine response different from that observed when the drugs were given in combination. However, the response to both agents in combination was significantly greater than that of isoproterenol alone. With respect to Vmax HeO2, there were significant increases after isoproterenol and after both drugs in combination, but there was a smaller and less consistent change after atropine. When the atropine response was further compared to that of isoproterenol and the combined regimen, the atropine response was found to be significantly smaller. The resulting density-dependence ratios fell significantly after atropine, increased after isoproterenol, and were unchanged from control when both drugs were combined. Upstream resistances on air were consistently smaller after all three bronchodilator regimens. However, the decrease in HeO2 Rus was not significant after atropine and was significantly less than the decreases after the other two regimens. Fig. 1 depicts the density dependence ratios as a percent of vital capacity for all seven subjects studied. These data demonstrate that the pattern ofratios shown in Table I held true for all lung volumes below 50% vital capacity. Figure 2 displays the static deflational pressurevolume curves for all subjects before and after each regimen. It is apparent that no significant changes in the mean elastic properties of our subjects' lungs were induced by any of the bronchodilators given singly or in combination. Comparisons of individual curves also failed to show any effects. Table II contains the data from IVPF curves in the four subjects in whom such measurements were made. A representative example of the curves from which data were taken is shown in Fig. 3 . The Palv' was consistently lower after atropine, higher after isoproterenol, and unchanged after both drugs in combination. In addition, Palv' while breathing HeO2 was often lower than air both before and after the bronchodilators but the differences were not statistically significant. The Vmax values, density dependence ratios, and upstream resistances measured in this series of experiments are similar to those in the previous studies outlined above. Downstream resistance values derived from the data in Table II showed a significant fall after atropine (air, 2.93-2.29, paired t = 3.97, P < 0.05; HeO2, 1.66-1.34, paired t = 0.94, P, NS). There was a small yet consistent decrease in air and HeO2 Rus after all three bronchodilator regimens. (3) demonstrated that isoproterenol given in large doses reduced Pst(l). These authors suiggested that this was the basis for the greater increases in airways conductance rather than in maximal flows. Bouhuys and van de Woestijne (4) could find no changes in Pst(l) and concluded that isoproterenol made large airways more compliant and therefore increased their dynamic compressibility. Green and Mead (13) , studying the volume and time-dependent behavior of airway smooth muscle tone, concluded that a deep inspiration produced bronchodilation and suggested that, since isoproterenol abolished this time-dependence of Vmax, the reappearance of airway tone 70 and 25% of vital capacity during forced expiration (15) . Therefore upstream segments contain both small peripheral and larger, more central airways, and Vmax is highly density dependent in such subjects (16) . On the other hand, if EPP were located in peripheral airways where cross-sectional area is large and Reynolds numbers are small, Vmax would be less density dependent. Indeed such a peripheral location has been proposed to explain diminished density dependence due to peripheral airway obstruction in patients with obstructive lung disease (17) and in cigarette smokers without established disease (18) .
DISCUSSION
With bronchodilatation after isoproterenol, increasing density dependence could be explained, at least in part, by a more mouthward EPP location. On or in the degree of taper in the former (i.e., before bronchodilatation) upstream segment. To bring about the required redtuction in upstream resistance, EPP would then have to move toward the alveoli. Thus it is possible to explain the atropine results in terms of a more peripheral EPP movement. However, the data of Gardiner and colleagues (19) indicate that, in dog lungs, a more mouthward EPP location is found after bronchodilatation produced by vagotomy, which is presumably similar to atropine administration. We do not know if the distribution of innervation in human airways is similar to that seen in dogs. Nonetheless we must deal with the possibility that a mouthward shift of EPP might have occurred after atropine and such a shift would be expected, if anything, to increase density dependence. Hence the paradox that we must explain is a decrease in density dependence in association with a more mouthward location of EPP. For the sake of illustration, we will consider the upstream segment as having two subsegments, one of which consists of density-independent, small airways and the other density-dependent, large airways. With a constant Pst(l), if there were greater dilatation of large airways after atropine there would be a relatively greater proportion of the Pst(l) dissipated across small airways of this segment. The result would be a relatively greater increase in Vmax with air than with HeO2 (i.e., decrease in density dependence). In con- trast, greater dilatation of small airways would result in a proportionally greater pressure drop across larger airways of the upstream segment. The result in this instance would be a relatively greater increase in Vmax HeO2 than air (i.e., increase in density dependence). Thus we propose that atropine predominantly dilates large upstream airways with the result that there is an increase in the relative contribution of small airways to flow limitation, and isoproterenol would seem to produce predominant dilatation of small upstream airways which would increase the relative contribution of large upstream airways to flow limitation. If our hypothesis is valid that atropine dilates the larger airways within the upstream segment and isoproterenol preferentially dilates the smaller airways upstream from EPP, then both agents given simultaneously should result in increased Vmax and intermediate effects on density dependence. The data in Table I and Fig. 1 clearly demonstrate that this was the case. That the increase in flow did not approximate the sum of the increases in Vmax for each agent given separately can probably be explained by considering the relative distribution of parasympathetic and sympathetic influences on airway caliber. In dog lungs the parasympathetic nervous system appears to exert a constricting influence at all levels of the tracheobronchial tree but the dilatation after vagotomy occurs predominantly in larger airways (3-8 mm in diameter) (20) . Beta adreneregic agents might preferentially exert their dilator effect on the peripheral airways since propranolol administration results in increased peripheral airway resistance (5) . Therefore it is not surprising that the anticholinergic agent resulted in greater increases in Vmax than beta adrenergic stimulation alone. Moreover, since there is no doubt that there is some overlap in the sites of action of each agent, the administration of both together would not be expected to result in an algebraic sum of the increases in Vmax when given separately.
From the IVPF curves, the demonstrated decreases in Palv' after atropine indicate that downstream airways were affected more than upstream airways. Since it is unlikely that large upstream airways could be dilated without a measureable change in downstream airways, the fall in Palv' is consistent with our interpretation of the atropine results (Table II) . After the administration of isoproterenol, the findings of a fall in Rus with both gases and an increase in Palv' taken together indicate greater dilatation of upstream than downstream airways. It might be argued that isoproterenol had an effect on larger airways equivalent to that of atropine, but with a greater effect on small airways. However, since resistance of downstream segment decreased significantly (from a mean of 2.92-2.28, P < 0.05) after atropine and did not change after isoproterenol (from a mean of 3.02-2.94, P, NS), we think the latter argument unlikely to be true, although, undoubtedly, isoproterenol has some effect on larger airways.
It is of interest to compare in some detail our findings with those of McFadden et al. (3) . They were the first to point out that changes in Palv' could be used to interpret the distribution of airway resistance changes and, indeed, that such changes, according to EPP concepts, would be related to this distribution and to Pst(l), but unrelated to total airway resistance. In their experiments with aerosolized isoproterenol, small but consistent reductions in Pst(l) had a dominant effect on Palv' such that they found a slight reduction in contrast to the increase we have found. We are unable to explain the different findings with regard to Pst(l) in the two studies except to note that their dose was approximately twice that used in this study. Yet is is interesting that our failure to find changes in Pst(l) rendered Palv' solely dependent upon resistance distribution. Using their method of analysis, we have concluded that the changes with isoproterenol are not uniformly distributed, as they suggested. On closer examination, several of their findings are consistent with our conclusions. First they observed that the greatest percentage change in flow rates occurred at volumes below 50% of vital capacity and they pointed out that "at small lung volumes the increase in flow is, if anything, more pronounced than the changes in conductance." Since as lung volume decreases, peripheral airways contribute progressively more to upstream resistance, this volume dependence is consistent with predominant peripheral dilatation. Second they applied their measurements of Pst(l) to their eq. 5 and, in solving for the ratio of downstream to upstream resistance, they found slight increases. They emphasized the variability of their estimates of Palv' and concluded that the increase in airway dimensions was relatively evenly distributed within the tracheobronchial tree. However, it is worth noting that the direction of change in the ratio is what would be expected for predominantly peripheral airway dilatation.
How much would our interpretation of differing predominant sites of bronchodilatation be altered if there were different EPP locations with the two gases? Should EPP systematically have a more peripheral location with HeO2 than with air, the HeO2 peripheral airway (i.e. airways with internal diameters c 2 mm) resistance would approach the HeO2 upstream resistance as has been shown in dog lungs (21) . Failure of HeO2 Rus to change consistently and appreciably after atropine and the consistent fall in this value after isoproterenol ( 
